![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/nona-biosciences-announces-strategic-collaboration-with-genequantum-healthcare-to-empower-early-discovery-of-next-generation-bioconjugates-301985807.html
https://www.prnewswire.com/news-releases/genequantum-and-inxmed-have-reached-a-technology-licensing-collaboration-providing-strong-support-for-innovative-adc-drug-research-and-development-301878259.html
https://www.fiercebiotech.com/biotech/buoyed-preclinical-success-chinese-and-korean-biotechs-expand-adc-collaboration
https://www.prnewswire.com/news-releases/forge-stronger-partnership-for-advanced-adc-development-genequantum-healthcare-and-aimed-bio-collaborate-to-develop-five-innovative-adc-drugs-301871712.html
https://www.indianpharmapost.com/news/genequantum-and-wuxi-xdc-enter-into-strategic-cooperation-to-empower-innovative-bioconjugates-development-13503
https://www.prnewswire.com/news-releases/genequantum-healthcares-two-next-generation-bioconjugate-drugs-gq1005-and-gq1007-have-been-approved-for-clinical-trials-in-australia-301547439.html
https://www.prnewswire.com/news-releases/genequantum-and-aimedbio-collaborate-on-a-first-in-class-antibody--drug-conjugate-301526935.html
https://www.prnewswire.com/news-releases/genequantum-announces-two-key-leadership-appointments-301377483.html
https://www.prnewswire.com/news-releases/genequantum-and-brighgene-sign-agreement-for-development-of-antibody-immune-agonist-conjugates-301369524.html